Here, extending our earlier findings on feasibility of targeting NFκB in neoplastic B-cells, we propose a potential therapeutic approach which employs NAE inhibitor pevonedistat to facilitate extrinsic apoptosis in lymphoma. This evidence concerns the gene NFKB1 and lymphoma.